Anavex Life Sciences Corp (AVXL)

[Amatuer17]

Alz phase 3 trials are large and long duration.

Here are most current 2 examples

1. Lily - 2 P3 trials - 1150 and 2450 patients

2. Biogen - one P3 - 2700 patients

These are lasting for 3+ year each

Why you think AVXL can get special treatment?

AVXL still has not started P2 and then P3. Based on current finances, it does not seem that they can go alone with any P3 as there is no easy funding.

On the other hand they can use ACAD model - good P1 results --> 1st secondary offering raise money --> conduct P2 --> good P2 results --> SP goes up again --> another secondary offering (funding) --> trigger P3

P3 successful --> apply for approval market the profuct -No partner needed